Business Weekly

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

Here’s the rundown: Deals of the Week: Adam Neumann wants to buy WeWork from bankruptcy, Starship Technologies raised $90 million for a product that 100% of the crew love, and Ambience Healthcare’s massive $70 million round also got a warm reception for its target market. Lat ...  Show more

Managing technology has never been more challenging. HBR IdeaCast’s new special series, Tech at Work, offers research, stories, and advice to make technology work for you and your team. This week: how to prepare your company for the future of spatial computing. 

Join iHeartMedia Chairman and CEO Bob Pittman for the new season of Math & Magic: Stories from the Frontiers of Marketing.

This season, Bob sits down with leaders across various fields –from A-list entrepreneurs to a supersonic aviator and everyone in-between—to lea ...

**FIRST EPISODE - WEDNESDAY 30TH AUGUST** Does money really make the world go round? Economics, business and finance have long been subjects we leave to the stock brokers, hedge fund managers and business school professors who spend their lives obsessing over them - but there’s ...  Show more